Rishikesh Balvalli (@PathoGuy) profile picture

Ophthalmic Oncopathologist & Head of Laboratory Services @ Sankara Eye Foundation | Image Analysis Enthusiast | Collaborative & Translational Research

Bangalore
Joined October 2013
Photo by Rishikesh Balvalli (@PathoGuy)Photo by Rishikesh Balvalli (@PathoGuy)Photo by Rishikesh Balvalli (@PathoGuy)Photo by Rishikesh Balvalli (@PathoGuy)Photo by Rishikesh Balvalli (@PathoGuy)Photo by Rishikesh Balvalli (@PathoGuy)Photo by Rishikesh Balvalli (@PathoGuy)Photo by Rishikesh Balvalli (@PathoGuy)Photo by Rishikesh Balvalli (@PathoGuy)Photo by Rishikesh Balvalli (@PathoGuy)
Rishikesh Balvalli retweeted
CAR-T Ecosystem 360° Five Years of Building an Integrated CAR-T Cell Therapy Program — A Journey of Science, Teamwork and Persistence! CAR-T cell therapy is much more than administering genetically engineered immune cells. Its true complexity lies in understanding what happens before, during and after infusion — from cellular expansion and persistence to immune activation, toxicity, response and relapse. Over the last five years, our team at Amrita Hospital, Faridabad, has worked towards developing what we call CAR-T Ecosystem 360° — an integrated clinical and translational research framework that brings together advanced immune monitoring, cellular kinetics, clinical decision-making and collaborative research. @Dasleukemiapath @moushumi_surya @NitinJainMD @doctorpemm @Saphaltamedonc @ViditKapoor15 @RanjitKSMD @batraatulonc @nihardesai89 Our ecosystem integrates: 🔬 Immune Profiling: Monitoring an array of 35 cytokines and immune mediators to understand immune activation and toxicity. 🧬 Translational Research: ICMR-funded immune profiling studies, single-cell analysis and exploration of the immunobiology of cellular therapies. 📊 CAR-T Cell Kinetics: Longitudinal tracking through ddPCR and flow cytometry to study expansion, persistence and cellular dynamics. 🩺 Clinical Intelligence: Integrating clinical observations with immunological data to support early recognition of complications and timely, informed interventions. 🔗 National Collaboration: Receiving clinical queries and samples from cellular therapy centres across India, sharing our experience and contributing to collaborative scientific learning. Perhaps our most important achievement has been developing a deeper understanding of the biology and clinical behaviour of Indian CAR-T cell therapies through the continuous integration of clinical experience and translational research. What makes this journey especially meaningful is that we started from scratch and every capability has been built progressively through sustained teamwork, scientific curiosity and persistence. Our vision is to move beyond delivering CAR-T cells towards understanding the entire cellular therapy journey — from infusion to immune response, toxicity, persistence and long-term outcomes. Deeply grateful to our clinicians, scientists, laboratory colleagues, nursing teams and research collaborators who have made this journey possible. Five years into this journey, we have learnt enormously. And there is still so much more to discover! Publications from our group are aimed at providing a framework for further translational work in India 1. frontiersin.org/journals/imm… 2. sciencedirect.com/science/ar… 3. sciencedirect.com/science/ar… 4. link.springer.com/article/10… 5. sciencedirect.com/science/ar… #CARTEcosystem360 #CARTCellTherapy #CellularTherapy #Immunotherapy #TranslationalResearch #TeamScience #IndianCART
1
9
490
Sorry, but I'm out.
Introducing my new brand H.I.M. Handsome Indian Man with Co-Founder Ranveer Singh. Tested on Indian man. Engineered especially for the handsome Indian man. 🇮🇳 @himscience
47
Rishikesh Balvalli retweeted
Help us. We are facing a severe shortage of blood and blood products at @TataMemorial Please come forward to donate blood. If anybody your housing societies can arrange larger blood donation camps, we can organize them on site. Please DM me if this is possible, and help amplify this call. Your selfless gesture can help us continue services as usual at the hospital. Grateful for your help
130
2,002
121
2,043
220,930
Will anyone cure TB or atleast release an effective vaccine for it?
Anthropic CEO predicts cancer, Alzheimer's, heart disease, mental illness will be cured in less than 10 years ACCELERATE
51
Rishikesh Balvalli retweeted
Replying to @PathoGuy
Very rare but serious association About 6.4/10,000 users (vs 3.8/10,000 in non users) Diabetes and sleep apnea increase risk. Difficult to predict and no effective treatment . Association only, causation not proven Benefits of GLP outweigh risks in carefully chosen pts!
1
1
75
Rishikesh Balvalli retweeted
Dreamed, designed, developed — and finally reaching its intended destination! Chandra AspireX: Innovation with a purpose
14
34
6
162
38,194
Rishikesh Balvalli retweeted
Fellow doctors - especially those just graduating or preparing for NEET. I want to share a longish post. We recently had a batch reunion. A decade ago, our medical college batch conversations were a high-stakes highlight reel: which competitive post-graduation specialty did you crack, your rank, USMLE fellowship matches. We were defined entirely by our professional milestones. When our batch met recently, the vibe had completely shifted. Not a single person talked about their number of publications, the bed strength of their hospital, or how state-of-the-art their clinic setup is. Instead, we spent hours talking about our kids, navigating aging parents, our creative outlets, and what actually brings us a sense of purpose beyond the clinic doors. It made me reflect on the predictable arc of these milestones. Fast forward another decade, and I am certain our catch-ups will center around chronic health management, joint pains, and our children heading off to college. In fact, a few months ago, I watched my mother-in-law’s batch reunite and their entire evening revolved around health updates, grandchildren, and mutual care. We are often told to be relentlessly aggressive about our careers, to chase that ambitious specialization, and to build something we love showing up for every single day. That drive matters. But the things that feel like the absolute end of the world today the missed promotion, the delayed paper, the competitive benchmark..simply aren't! Life is a sum total of everything, not just professional CV Live fully, enjoy the present moment, and hold your near and dear ones tight.
6
21
4
190
11,290
Mr. Goyal, your intentions may be noble but your science is bogus. People will realise it sooner than later.
Dear Concerned Indian Doctors, I see your rage against Temple on X. I have a few points to make: 1. First and foremost, a business lesson: if Temple were a scam, and any of what we said weren't true, people would know it in just a few days of using Temple. We have 14-day, no-questions-asked returns (which even Apple doesn't offer in India). If the product doesn't work, it fails out of the gate and the company dies before recovering a tenth of its R&D. 2. We have already spent $30m building Temple, $20m out of which is my own money. Selling a few thousand devices recovers a small fraction of this investment. A scam that pays nothing is not a scam anyone would run. 3. I left the Eternal CEO role to chase purpose with Temple. This is not about money. I have enough of it to last for generations. My incentives are fully aligned with getting the science right. I am not staking a reputation earned over 20 years on making a quick buck. 4. Our employees bought into our round a few months ago. The round we're raising now is mostly our customers. Scams don't build that cap table. 5. Most wearable companies start with internal studies. Whoop shipped its band in 2015, and the first published validation followed a few years later. We hold ourselves to a higher standard; pre-prints are a step prior to peer reviewed publications, and they are coming up. 6. At some point you have to stick your neck out and say: we believe in our science, and the product is now valuable enough for people to pay for and use. We believe we are there. More validation continues in public. 7. We are confident that we are building something that the world is going to be positively astonished with. We stand by our science and our methods. Each of our claims is easily verifiable by individuals and institutions alike, and you will see a lot of independent studies come up on their own when the device becomes available to use. Last but not the least, the most ground breaking features in Temple are not even public yet. And some of them, thankfully, have nothing to do with doctors 🤭 Hope this addresses some or all of your concerns. If not, keep raging 😘🤗
6
209
Babus are great spinmasters!
The issue of the NEET-PG qualifying cut-off dropping so low that minus 40 marks qualified reached the Supreme Court. The Court sought the Centre's opinion. The Centre set up a 12-member expert committee, which proposed replacing marks-based merit with a rank-based system. The National Medical Commission approved it, and the proposal is now before the Court. This is a clever fix! The headline "Rank 2,00,000 secured MS Orthopedics in NEET-PG" sounds far less alarming to the public than "Candidate with minus 40 marks secured MS Orthopedics." Problem solved, outrage avoided, and public trust in the medical system restored.
1
67
Rishikesh Balvalli retweeted
It’s that time of year when I break my Twitter hiatus to talk about the Annual Book & Bake Sale! This year, we have over 5K books, and its our BEST collection yet! Everything will be sold for Rs 20-350, and the proceeds will support education for children in need. (1/20)
48
277
52
1,178
78,396
As a girl dad, I couldn't sleep last night after knowing about the Panchkula and AP incidents. Feeling of helplessness is real.
1
6
461
Rishikesh Balvalli retweeted
The harsh, unglamorous reality of running a research lab in India: • 9 months spent navigating bureaucratic loops just to onboard a single postdoctoral fellow. • Two nationally funded grants stuck in fiscal limbo, sanctioned on paper, zero cash flow in practice. • Project staff and research fellows surviving without salaries for 90 days. We celebrate Nobel dreams and technological self-reliance on public stages, but behind the laboratory doors, PIs spend 70% of their bandwidth begging finance desks to release sanctioned funds and apologizing to unpaid junior scholars. Science does not fail in India due to a lack of intellect or ambition; it gets slowly suffocated by procedural inertia and financial apathy. If we cannot ensure basic salary timelines for young researchers, talking about global leadership is pure theater. 🎯☕📊🔬 #IndianAcademia #ResearchFunding #HigherEdRealities #SciencePolicy #PostDocStruggles #AcademicLeadership #SystemicReform
46
245
25
938
31,862
Rishikesh Balvalli retweeted
I've said this before: the majority of people who use AI (and I'm not talking about programmers or people who actually have to constantly run agentic tasks at desk or other truly token-hungry stuff like that, but just the typical person using ChatGPT as a replacement for Google) could simply download an open-source model, run it locally on their home PC, and get a perfectly acceptable result. Altman is mortally afraid of the average AI user figuring that out.
OpenAI CEO Sam Altman says it’s “quite terrible” that people have so much DRAM sitting in their own PCs instead of being used in data centers. “Everyone have a bunch of the world’s limited supply of DRAM sitting in their own computer. And be used 5% of the time,” He argues that cloud data centers should make better use of limited memory supplies instead of people running AI models locally.
183
1,384
54
11,343
591,296
Rishikesh Balvalli retweeted
Most Indian residencies and fellowships in surgical fields are just this. Humiliation- even if you do your job well- by mediocre guys who have punched below their weight all their lives & get a trip on having a sub-ordinate to berate on. I dodged the bullet in my residency!
one of the most humiliating things about corporate life is watching a grown man get scolded like a child in front of his coworkers. we’re all adults trying to make a living. you can correct someone’s mistakes without stripping them of their dignity.
5
12
2
124
10,724
Rishikesh Balvalli retweeted
It’s kinda crazy to me that we melt sand down, clean it to 99.99999% purity, literal wizards have to draw it slowly into an ingot, we cut it, inscribe a hundred billion little on/off switches on it, and when you run electric current through it you can do basic arithmetic, which when you do enough of it can do any math on the planet, and which describes reality well enough that we can teach it the ontological meaning of words and their distance from each other on a high-dimensional space, and if you ask, it can tell you what word comes next and that apparently is powerful enough that if you do it a hundred billion times it’s the smartest thing to ever exist oh yeah and we use this primarily for email
217
971
108
12,301
450,832
Rishikesh Balvalli retweeted
Frequently write about practices in the health insurance sector, particularly regarding Care Health Insurance. Recently, a patient with severe aortic stenosis consulted me. We provided an estimated procedure cost of approximately ₹7 lakh. The patient has a base mediclaim policy of ₹5 lakh along with a ₹45 lakh top-up cover. ​Because Care Health Insurance often disburses less than the sanctioned amount to our patients and doesn't pay if there is any complications ,we routinely ask for an upfront deposit. Now, the insurer is actively steering the patient toward a large corporate facility like Kokilaben Hospital, where the exact same surgery will likely cost at least ₹12- 15 lakh. ​When the procedure could be completed safely for ₹7 lakh, why is the insurer willing to pay upwards of ₹15 lakh to a corporate hospital?( same valve , same sutures , same outcome , only big hospital) Who ultimately absorbs this inflated cost? Policyholders do, through steadily climbing premiums. ​This is precisely why I continue to raise this issue: the growing nexus between insurance companies and large corporate chains threatens to eliminate smaller nursing homes and standalone hospitals—and policyholders are left paying the price. Remember - I am writing again - slowly all small hospitals and Nursing home will close down - only large corporate hospitals will survive and your mediclaim premium will be exorbitantly high .
13
83
4
221
31,450
Should not take people with follower counts as a flex seriously.
The top 3 medical specialties that AI should largely replace within the next 5 years: 1. Radiology 2. Ophthalmology 3. Pathology Any specialty heavily dependent on interpreting images, scans, or patterns is going to face ENORMOUS disruption. And this should ultimately mean faster diagnoses, much lower costs, and better access for patients. What specialty am I missing?
4
285
Rishikesh Balvalli retweeted
MATTER OF GREAT PRIDE FOR INDIAN SCIENCE!   Ashoke Sen becomes the first Indian to win the prestigious Oskar Klein Medal (2026), jointly  awarded by Stockholm University and the Nobel Committee for Physics of the Royal Swedish Academy of Sciences for his pioneering work in String theory.   deccanherald.com/science/ben…   String theory gives a unified description of all matter and the forces between them based on the postulate that the elementary constituents of matter are tiny one dimensional (string-like) objects instead of point particles. Sen’s breakthrough work has shown that multiple string theories are all different versions of a single underlying theory.   Incidentally, I met Ashok Sen for the first time, when both of us were elected  as FRS (Fellows of Royal Society) in 1998. Ashoke ( nominated by Stephen Hawking himself) was young 42 yrs and I was an oldie - 55 yrs though!   What struck me was Ashoke’s  incredible simplicity. His wife Sumathi Rao has reportedly said that Ashoke bought his first suit and needed some assistance to wear his first tie for that prestigious 1998 FRS ceremony in London, when one signs in the same book that Sir Isaac Newton has signed.   A film made on the life and work of Ashoke Sen, when we at the H K Firodia Award in Science & Technology honoured him in 2005 in Pune, will inspire all our budding scientists - showing how science & simplicity goes together. youtu.be/CoVc5cM5XlU?si=vQNQ… We all feel so so proud Ashoke! @PMOIndia @NITIAayog @PrinSciAdvOff @IndiaDST @CSIR_IND @ictstifr @PuneIntCentre @kvijayraghavan
49
505
32
1,811
45,778
Delhi Bangalore one way ticket is 15000.
India targets 130 Crore air passengers by 2047: Ram Mohan Naidu
1
57